BlackRock Health Sciences Trust (NYSE:BME – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totaling 42,500 shares, an increase of 286.4% from the March 31st total of 11,000 shares. Based on an average daily trading volume, of 39,700 shares, the days-to-cover ratio is presently 1.1 days.
BlackRock Health Sciences Trust stock opened at $43.73 on Thursday. BlackRock Health Sciences Trust has a 1 year low of $40.75 and a 1 year high of $49.98. The firm has a 50 day moving average price of $44.17 and a 200 day moving average price of $45.80.
The company also recently announced a monthly dividend, which will be paid on Friday, April 29th. Stockholders of record on Thursday, April 14th will be given a dividend of $0.213 per share. The ex-dividend date is Wednesday, April 13th. This represents a $2.56 dividend on an annualized basis and a dividend yield of 5.84%.
Hedge funds have recently added to or reduced their stakes in the business. Raymond James & Associates boosted its holdings in shares of BlackRock Health Sciences Trust by 3.2% during the third quarter. Raymond James & Associates now owns 26,391 shares of the company’s stock worth $1,258,000 after purchasing an additional 825 shares during the period. Kestra Advisory Services LLC increased its position in BlackRock Health Sciences Trust by 4.3% during the fourth quarter. Kestra Advisory Services LLC now owns 21,684 shares of the company’s stock worth $1,052,000 after acquiring an additional 897 shares during the period. LPL Financial LLC increased its position in BlackRock Health Sciences Trust by 7.1% during the third quarter. LPL Financial LLC now owns 42,123 shares of the company’s stock worth $2,007,000 after acquiring an additional 2,781 shares during the period. Oppenheimer & Co. Inc. increased its position in BlackRock Health Sciences Trust by 30.5% during the third quarter. Oppenheimer & Co. Inc. now owns 6,106 shares of the company’s stock worth $291,000 shares after acquiring an additional 1,426 during the period. Finally, TRU Independence Asset Management 2 LLC acquired a new stake in BlackRock Health Sciences Trust during the third quarter worth $1,191,000.
About BlackRock Health Sciences Trust (Get Rating)
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Receive News & Ratings for BlackRock Health Sciences Trust Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com’s FREE daily email newsletter.